• Meeting abstract

Secukinumab provides clearer skin and better control on patient-reported psoriasis symptoms of itching, pain, and scaling than placebo and etanercept

Citation

Strober, B., Sigurgeirsson, B., Popp, G., Sinclair, R., Krell, J., & Mordin, M. (2016). Secukinumab provides clearer skin and better control on patient-reported psoriasis symptoms of itching, pain, and scaling than placebo and etanercept. Journal of Psoriasis and Psoriatic Arthritis , 1(4), 167-175.